Cargando…
COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics
The SARS-CoV-2 novel coronavirus has caused the COVID-19 pandemic with over 35 million cases and over a million deaths worldwide as of early October 2020. The populations most affected are the elderly and especially those with underlying comorbidities. In terms of race and ethnicity, black and hispa...
Autores principales: | Spihlman, Allison P., Gadi, Nirupa, Wu, Samantha C., Moulton, Vaishali R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661632/ https://www.ncbi.nlm.nih.gov/pubmed/33193418 http://dx.doi.org/10.3389/fimmu.2020.589474 |
Ejemplares similares
-
What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
por: Gadi, Nirupa, et al.
Publicado: (2020) -
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
por: Bajaj, Varnica, et al.
Publicado: (2021) -
Editorial: Focusing on T-Cells for Novel Treatments of Systemic Lupus Erythematosus
por: Ichinose, Kunihiro, et al.
Publicado: (2021) -
Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
por: Katsuyama, Takayuki, et al.
Publicado: (2018) -
Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)